Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Apr 14;12(1):1-17.
doi: 10.1556/1886.2021.00021. Online ahead of print.

Tuberculosis challenges: Resistance, co-infection, diagnosis, and treatment

Mohsen Heidary  1   2 , Maryam Shirani  3 , Melika Moradi  4 , Mehdi Goudarzi  5 , Ramin Pouriran  6 , Tayebe Rezaeian  7 , Saeed Khoshnood  8
Affiliations
Review

Tuberculosis challenges: Resistance, co-infection, diagnosis, and treatment

Mohsen Heidary et al. Eur J Microbiol Immunol (Bp). .

Abstract

Early diagnosis of tuberculosis (TB), followed by effective treatment, is the cornerstone of global TB control efforts. An estimated 3 million cases of TB remain undetected each year. Early detection and effective management of TB can prevent severe disease and reduce mortality and transmission. Intrinsic and acquired drug resistance of Mycobacterium tuberculosis (MTB) severely restricted the anti-TB therapeutic options, and public health policies are required to preserve the new medications to treat TB. In addition, TB and HIV frequently accelerate the progression of each other, and one disease can enhance the other effect. Overall, TB-HIV co-infections show an adverse bidirectional interaction. For HIV-infected patients, the risk of developing TB disease is approximately 22 times higher than for persons with a protective immune response. Analysis of the current TB challenges is critical to meet the goals of the end TB strategy and can go a long way in eradicating the disease. It provides opportunities for global TB control and demonstrates the efforts required to accelerate eliminating TB. This review will discuss the main challenges of the TB era, including resistance, co-infection, diagnosis, and treatment.

Keywords: Mycobacterium tuberculosis; coinfection; diagnosis; resistance; treatment; tuberculosis.

PubMed Disclaimer

Conflict of interest statement

Authors declare that they have no competing interests

References

    1. Zaman K. Tuberculosis: a global health problem. J Health Popul Nutr 2010;28(2):111. - PMC - PubMed
    1. Zhang Y, Liu X, Yang L, Zhang G, Gu Z, Chen Z, et al. . Barriers and strategies: a review of access to affordable multi-drug resistant tuberculosis medication in China. Infect Drug Resist 2020;13:3679. - PMC - PubMed
    1. Ahmad S, Mokaddas E. Recent advances in the diagnosis and treatment of multidrug-resistant tuberculosis. Respir Med CME 2010;3(2):51–61. - PubMed
    1. Adeniji AA, Knoll KE. Potential anti-TB investigational compounds and drugs with repurposing potential in TB therapy: a conspectus. Appl Microbiol Biotechnol 2020;104(13):5633–5662. - PubMed
    1. Montales MT, Chaudhury A, Beebe A, Patil S, Patil N. HIV-associated TB syndemic: a growing clinical challenge worldwide. Public Health Front 2015;3:281. - PMC - PubMed

LinkOut - more resources